Philippe Halfon

11.2k total citations · 1 hit paper
223 papers, 7.8k citations indexed

About

Philippe Halfon is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Philippe Halfon has authored 223 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 149 papers in Epidemiology, 128 papers in Hepatology and 58 papers in Infectious Diseases. Recurrent topics in Philippe Halfon's work include Hepatitis C virus research (124 papers), Hepatitis B Virus Studies (94 papers) and Liver Disease Diagnosis and Treatment (84 papers). Philippe Halfon is often cited by papers focused on Hepatitis C virus research (124 papers), Hepatitis B Virus Studies (94 papers) and Liver Disease Diagnosis and Treatment (84 papers). Philippe Halfon collaborates with scholars based in France, United States and Italy. Philippe Halfon's co-authors include Marc Bourlière, Guillaume Pénaranda, Hacène Khiri, P. Cacoub, Stephen Locarnini, Denis Ouzan, Thierry Poynard, J. Durant, P. Dellamonica and Philippe Clevenbergh and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Philippe Halfon

216 papers receiving 7.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Drug-resistance genotyping in HIV-1 therapy: the VIRAD APT randomi sed controlled trial

1999 559 citations J. Durant, Philippe Halfon et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philippe Halfon France	48	4.7k	4.1k	2.4k	1.6k	783	223	7.8k
F. Blaine Hollinger United States	46	5.4k 1.2×	4.6k 1.1×	1.7k 0.7×	961 0.6×	710 0.9×	164	7.9k
Kenneth E. Sherman United States	44	5.8k 1.2×	6.7k 1.7×	2.2k 0.9×	690 0.4×	562 0.7×	250	8.7k
Michael Robertson United States	38	3.3k 0.7×	2.2k 0.5×	2.2k 0.9×	2.2k 1.3×	1.0k 1.3×	137	6.4k
Shyam Kottilil United States	41	3.8k 0.8×	3.1k 0.8×	1.9k 0.8×	1.8k 1.1×	680 0.9×	209	7.6k
Jacquie Astemborski United States	44	4.6k 1.0×	3.5k 0.9×	2.0k 0.8×	1.2k 0.7×	226 0.3×	115	7.2k
Sugantha Govindarajan United States	55	6.7k 1.4×	7.9k 2.0×	2.0k 0.9×	544 0.3×	1.0k 1.3×	180	10.4k
Massimo Puoti Italy	47	6.6k 1.4×	7.0k 1.7×	2.5k 1.0×	651 0.4×	285 0.4×	263	9.1k
Arthur Y. Kim United States	38	2.7k 0.6×	3.3k 0.8×	1.2k 0.5×	658 0.4×	390 0.5×	121	4.9k
Margaret James Koziel United States	42	4.4k 0.9×	5.1k 1.3×	1.1k 0.5×	797 0.5×	327 0.4×	98	6.8k
Andrew H. Talal United States	35	2.6k 0.6×	2.9k 0.7×	1.2k 0.5×	1.3k 0.8×	218 0.3×	141	5.1k

Countries citing papers authored by Philippe Halfon

Since Specialization

Citations

This map shows the geographic impact of Philippe Halfon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Halfon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Halfon more than expected).

Fields of papers citing papers by Philippe Halfon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Halfon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Halfon. The network helps show where Philippe Halfon may publish in the future.

Co-authorship network of co-authors of Philippe Halfon

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Halfon. A scholar is included among the top collaborators of Philippe Halfon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Halfon. Philippe Halfon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Halfon, Philippe, et al.. (2025). High prevalence of small intestinal bacterial overgrowth and intestinal methanogen overgrowth in endometriosis patients: A case–control study. International Journal of Gynecology & Obstetrics. 170(1). 284–291. 3 indexed citations

Ureña, Raquel, Sabine Camiade, Martine Piarroux, et al.. (2024). Proof of concept study on early forecasting of antimicrobial resistance in hospitalized patients using machine learning and simple bacterial ecology data. Scientific Reports. 14(1). 22683–22683. 1 indexed citations

Bestion, Eloïne, Éric Raymond, Soraya Mezouar, & Philippe Halfon. (2023). Update on Autophagy Inhibitors in Cancer: Opening up to a Therapeutic Combination with Immune Checkpoint Inhibitors. Cells. 12(13). 1702–1702. 12 indexed citations

Ureña, Raquel, Sabine Camiade, Martine Piarroux, et al.. (2023). Leveraging Bacterial Ecology Data with Machine Learning Algorithms for Precise Prediction of Antimicrobial Resistance in Hospitalized Patients. SSRN Electronic Journal. 1 indexed citations

Harding, James J., Ahmad Awada, Gaël S. Roth, et al.. (2022). First-In-Human Effects of PPT1 Inhibition Using the Oral Treatment with GNS561/Ezurpimtrostat in Patients with Primary and Secondary Liver Cancers. Liver Cancer. 11(3). 268–277. 16 indexed citations

Boumaza, Asma, Laëtitia Gay, Soraya Mezouar, et al.. (2021). Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 Immunoparalysis. The Journal of Infectious Diseases. 224(3). 395–406. 117 indexed citations

Diallo, Aldiouma, Fabienne Marcellin, Marion Coste, et al.. (2021). Hepatitis B in Senegal: A Successful Infant Vaccination Program but Urgent Need to Scale Up Screening and Treatment (ANRS 12356 AmBASS survey). Hepatology Communications. 6(5). 1005–1015. 9 indexed citations

Camus, Claire, Guillaume Pénaranda, Hacène Khiri, et al.. (2018). Quantification of HPV16 E6/E7 mRNA Spliced Isoforms Viral Load as a Novel Diagnostic Tool for Improving Cervical Cancer Screening. Journal of Clinical Medicine. 7(12). 530–530. 8 indexed citations

Jarrot, Pierre‐André, Laurent Chiche, B. Hervier, et al.. (2016). Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Overlap Syndrome in Patients With Biopsy-Proven Glomerulonephritis. Medicine. 95(22). e3748–e3748. 54 indexed citations

10.

Halfon, Philippe. (2012). HCV resistance. Retrovirology. 9(S1). 1 indexed citations

11.

Bataille, Stanislas, Gilles Kaplanski, José Boucraut, et al.. (2012). Membranoproliferative Glomerulonephritis and Mixed Cryoglobulinemia after Hepatitis C Virus Infection Secondary to Glomerular NS3 Viral Antigen Deposits. American Journal of Nephrology. 35(2). 134–140. 15 indexed citations

12.

Halfon, Philippe, Marc Bourlière, Denis Ouzan, et al.. (2010). 1167 IL-28 GENE VARIATION PREDICTS WHO WILL RESPOND TO INTERFERON-BASED TREATMENT OF CHRONIC HEPATITIS C IN A FRENCH COHORT. Journal of Hepatology. 52. S451–S451. 2 indexed citations

13.

Halfon, Philippe, F. Rétornaz, Didier Mathieu, et al.. (2009). Virus-associated hemophagocytic syndrome related to acute CMV and HBV sexual co-infection: A case report. Journal of Clinical Virology. 46(2). 189–191. 4 indexed citations

14.

Rosenthal‐Allieri, Maria Alessandra, Albert Tran, Philippe Halfon, et al.. (2007). Optimal correlation between different instruments for Fibrotest-Actitest protein measurement in patients with chronic hepatitis C. Gastroentérologie Clinique et Biologique. 31(10). 815–821. 4 indexed citations

15.

Poynard, Thierry, Philippe Halfon, Laurent Castéra, et al.. (2007). Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation. Alimentary Pharmacology & Therapeutics. 25(6). 733–739. 81 indexed citations

16.

Chiavérini, C., et al.. (2003). Porphyria cutanea tarda, C282Y, H63D and S65C HFE Gene Mutations and Hepatitis C Infection: A Study from Southern France. Dermatology. 206(3). 212–216. 13 indexed citations

17.

Cacoub, P., Éric Rosenthal, V. Gérolami, et al.. (2003). Transfusion-associated TT virus co-infection in patients with hepatitis C virus is associated with type II mixed cryoglobulinemia but not with B-cell non-Hodgkin lymphoma. Clinical Microbiology and Infection. 9(1). 39–44. 12 indexed citations

18.

Bourlière, Marc, Philippe Halfon, & Isabelle Portal. (2002). Hépatite chronique C traitement des groupes particuliers.. Gastroentérologie Clinique et Biologique. 26. 238–247. 1 indexed citations

19.

Durant, J., Philippe Halfon, Albert Tran, et al.. (1998). High prevalence of GB virus C/hepatitis G virus infection in different risk groups of HIV-infected patients. Clinical Microbiology and Infection. 4(11). 644–647. 4 indexed citations

20.

Rotily, Michel, Sandrine Loubière, Judith M. Nixon, et al.. (1997). Faut-il dépister l'hépatite C? Analyse socio(-)économique de différentes stratégies de dépistage de l'hépatite chronique C dans la population française.. Gastroentérologie Clinique et Biologique. 21. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact